Iovance Biotherapeutics Inc (IOVA) Stock Analysis

Iovance Biotherapeutics Inc (IOVA) is a publicly traded company in the HEALTHCARE sector. It trades at $4.10, carries a market capitalization of $1.77B. This page summarizes the public market data, fundamentals, and frequently asked questions for IOVA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Iovance Biotherapeutics Inc currently has a Bullish sentiment score of 0.44.

About Iovance Biotherapeutics Inc

Iovance Biotherapeutics, Inc. is a leading clinical-stage biotechnology company located in San Carlos, California, focused on transformative cancer immunotherapy through its innovative tumor-infiltrating lymphocyte (TIL) therapy. This proprietary approach harnesses the power of the patient's immune system to effectively target and combat various malignancies, particularly melanoma and cervical cancer. With an advancing pipeline and a dedication to scientific rigor, Iovance is strategically po...

GNG Research Analysis

GNG Research scores Iovance Biotherapeutics Inc (IOVA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for IOVA.

Frequently Asked Questions

Does IOVA pay dividends?

Iovance Biotherapeutics Inc (IOVA) does not currently pay a regular dividend.

What is IOVA's market cap?

Iovance Biotherapeutics Inc (IOVA) has a market capitalization of $1.77B with a current stock price of $4.10.